Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsChild and adolescent psychiatry — early-onset psychosis

Psych · Child and adolescent psychiatry — early-onset psychosis

Early-onset psychosis

Also known as EOP · Early onset psychosis · Childhood-onset schizophrenia · COS · Very-early-onset schizophrenia · VEOS · Adolescent-onset psychosis · Paediatric schizophrenia · Youth psychosis · Early-onset schizophrenia spectrum

Exam-exhaustive CAP fellowship reference on early-onset psychosis — age definitions (EOP under 18, VEOP/COS under 13), autism/trauma/substance differentials, intensified organic work-up, youth early intervention, start-low antipsychotics with metabolic vigilance, family and school liaison, and clozapine threshold in refractory EOP. Related to adult FEP/schizophrenia but CAP-specific. FRANZCP-primary, globally tagged.

high22 referencesUpdated 26 July 202613 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • New psychosis with fever, fluctuating attention, seizure, dysautonomia, movement disorder or rapid cognitive decline — exclude encephalitis, delirium and other organic causes before locking a primary EOP label
  • Childhood onset under 13 with progressive decline — rare, often severe; intensify medical, developmental and genetic work-up
  • Active suicidal intent, command hallucinations to harm, severe aggression, or child protection risk — same-day senior review, means restriction, multi-agency safety plan
  • Catatonia, NMS features, or severe agitation with medical compromise — treat as medical-psychiatric emergency
  • Two adequate adherent antipsychotic failures — escalate toward clozapine pathway rather than endless non-clozapine cycling
  • Rapid weight gain or emerging metabolic syndrome after first antipsychotic exposure in youth — act early; do not wait for adult thresholds
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • New psychosis with fever, fluctuating attention, seizure, dysautonomia, movement disorder or rapid cognitive decline — exclude encephalitis, delirium and other organic causes before locking a primary EOP label
  • Childhood onset under 13 with progressive decline — rare, often severe; intensify medical, developmental and genetic work-up
  • Active suicidal intent, command hallucinations to harm, severe aggression, or child protection risk — same-day senior review, means restriction, multi-agency safety plan
  • Catatonia, NMS features, or severe agitation with medical compromise — treat as medical-psychiatric emergency
  • Two adequate adherent antipsychotic failures — escalate toward clozapine pathway rather than endless non-clozapine cycling
  • Rapid weight gain or emerging metabolic syndrome after first antipsychotic exposure in youth — act early; do not wait for adult thresholds
The one-line answer

Early-onset psychosis is a CAP time-critical pathway: fix the age band (EOP under 18; VEOP or COS under 13), exclude organic disease and the hard CAP differentials (autism, trauma, substance), start a low-dose antipsychotic with a full metabolic and ECG baseline from the very first exposure, deliver multi-element youth care with family and school as core modules, and escalate to clozapine after two adequate failures rather than endless second-generation cycling.[1][2][3][4]

Meet the patient

A 15-year-old has stopped going to school. For three months he has been convinced his teachers are editing the lecture recordings to humiliate him, and he hears two voices arguing about his marks. He has smoked high-potency cannabis daily since he was 13.[9][13]

The registrar calls it drug-induced. The examiner's question is the one that decides prognosis: "How long has he been psychotic, and how fast can you shorten that clock?" Duration of untreated psychosis is the single most modifiable variable on the page — in youth as in adults.[9][10]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References22ShowHide
  1. [1]Sikich L, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study Am J Psychiatry, 2008.PMID 18794207
  2. [2]Kumra S, et al. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison Biol Psychiatry, 2008.PMID 17651705
  3. [3]Correll CU, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents JAMA, 2009.PMID 19861668
  4. [4]McClellan J, Stock S Practice parameter for the assessment and treatment of children and adolescents with schizophrenia J Am Acad Child Adolesc Psychiatry, 2013.PMID 23972700
  5. [5]Stafford MR, et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis PLoS One, 2015.PMID 25671707
  6. [6]Pagsberg AK, et al. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised TEA trial Lancet Psychiatry, 2017.PMID 28599949
  7. [7]Kendall T, et al. Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance BMJ, 2013.PMID 23344308
  8. [8]Galletly C, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders Aust N Z J Psychiatry, 2016.PMID 27106681
  9. [9]Marshall M, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review Arch Gen Psychiatry, 2005.PMID 16143729
  10. [10]Correll CU, et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression JAMA Psychiatry, 2018.PMID 29800949
  11. [11]Kane JM, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program Am J Psychiatry, 2016.PMID 26481174
  12. [12]Howes OD, Kapur S The dopamine hypothesis of schizophrenia: version III--the final common pathway Schizophr Bull, 2009.PMID 19325164
  13. [13]Di Forti M, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study Lancet Psychiatry, 2019.PMID 30902669
  14. [14]Zipursky RB, Menezes NM, Streiner DL Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review Schizophr Res, 2014.PMID 23972821
  15. [15]Pharoah F, et al. Family intervention for schizophrenia Cochrane Database Syst Rev, 2010.PMID 21154340
  16. [16]Schoeler T, et al. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study Lancet Psychiatry, 2016.PMID 27567467
  17. [17]Hollis C Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity Am J Psychiatry, 2000.PMID 11007720
  18. [18]Clemmensen L, Vernal DL, Steinhausen HC A systematic review of the long-term outcome of early onset schizophrenia BMC Psychiatry, 2012.PMID 22992395
  19. [19]Driver DI, et al. Childhood-Onset Schizophrenia and Early-onset Schizophrenia Spectrum Disorders: An Update Child Adolesc Psychiatr Clin N Am, 2020.PMID 31708054
  20. [20]Rapoport JL, Gogtay N Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder Int J Dev Neurosci, 2011.PMID 20955775
  21. [21]Findling RL, et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia Am J Psychiatry, 2008.PMID 18765484
  22. [22]Gardner DM, et al. International consensus study of antipsychotic dosing Am J Psychiatry, 2010.PMID 20360319

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousDuty to warn and third-party riskForensic psychiatry — duty to warn and third-party riskNextEating disorders in adolescenceChild and adolescent psychiatry — eating disorders